Merger Notification - Announcement according to § 10 Cartel Act
Grünenthal GmbH; Nebido-Geschäft (derzeit kontrolliert von Bayer)
BWB/Z-6014
On 15.07.2022 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Grünenthal GmbH (Germany) intends to acquire Bayer Group’s assets related to their pharmaceutical product Nebido (testosterone undecanoate) (also marketed as
Reandron and Nebid).
Economic sector: production of pharmaceuticals
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 12.08.2022.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 13.08.2022 .